デジタル病理検査の市場規模、シェア、成長分析、製品別、タイプ別、用途別、最終用途別、地域別 - 産業予測 2025-2032年

デジタル病理検査の世界市場規模は、2023年に9億米ドルと評価され、2024年の9億7,000万米ドルから2032年には17億7,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは7.8％で成長する見通しです。

デジタル病理検査市場は、がんや心血管疾患の罹患率の増加により、精密な診断ツールが必要とされ、大きな成長を遂げています。慢性疾患の増加により、この分野の主要企業が開発した先進的なデジタル病理検査システムの需要が高まっています。Medscapeによると、死亡率の上昇はこれらの疾患と相関しており、さらなる技術革新の原動力となっています。デジタル病理検査は、巨視的画像の整理と画像解析手法の実装により、調査パイプラインを強化します。さらに、遠隔評価やリアルタイムの診察のための遠隔病理学ソリューションへの依存の高まりとともに、政府からの資金援助が市場拡大を後押しする主な要因となっています。これらの技術が進化するにつれて、診断の強化が促進され、より効率的なヘルスケア環境が育まれます。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

デジタル病理検査市場規模：製品別& CAGR（2025-2032）

• 市場概要
• スキャナー
  • 明視野スキャナー
  • 蛍光スキャナー
  • その他のスキャナー
• ソフトウェア
  • 統合ソフトウェア
  • スタンドワンソフトウェア
• 展開モデル
  • クラウドベースモデル
  • オンプレミスモデル
  • ハイブリッドモデル
• ストレージシステム

デジタル病理検査市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• 人間の病理学
• 獣医病理学

デジタル病理検査市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 医薬品の発見と開発
• 学術調査
• 病気の診断
  • がん細胞の検出
  • その他

デジタル病理検査市場規模：最終用途別& CAGR（2025-2032）

• 市場概要
• 病院
• バイオテクノロジー・製薬会社
• 診断ラボ
• 学術調査機関

デジタル病理検査市場規模& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024年）

主要企業プロファイル

• Koninklijke Philips N.V.（Netherlands）
• F. Hoffmann-La Roche Ltd（Switzerland）
• Hamamatsu Photonics K.K.（Japan）
• Olympus Corporation（Japan）
• PerkinElmer, Inc.（United States）
• 3DHISTECH Ltd.（Hungary）
• Sectra AB（Sweden）
• Visiopharm A/S（Denmark）
• Apollo Enterprise Imaging Corporation（Canada）
• Corista LLC（United States）
• Paige.AI, Inc.（United States）
• Ibex Medical Analytics Ltd.（Israel）
• Indica Labs, Inc.（United States）
• Proscia Inc.（United States）
• Deep Lens Inc.（United States）
• Aiforia Technologies Oyj（Finland）
• OptraSCAN, Inc.（United States）
• Mikroscan Technologies, Inc.（United States）
• Xilis, Inc.（United States）

結論と提言

Global Digital Pathology Market size was valued at USD 0.9 billion in 2023 and is poised to grow from USD 0.97 billion in 2024 to USD 1.77 billion by 2032, growing at a CAGR of 7.8% during the forecast period (2025-2032).

The digital pathology market is experiencing significant growth due to the increasing incidence of cancer and cardiovascular diseases, necessitating precise diagnostic tools. The rise in chronic illnesses has heightened the demand for advanced digital pathology systems developed by major players in the field. According to Medscape, an uptick in mortality rates correlates with these conditions, driving further innovation. Digital pathology enhances research pipelines by organizing macroscopic images and implementing image analysis methods. Additionally, government funding, along with the growing reliance on telepathology solutions for remote evaluations and real-time consultations, are key factors propelling market expansion. As these technologies evolve, they facilitate enhanced diagnostics, fostering a more efficient healthcare landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Digital Pathology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Digital Pathology Market Segments Analysis

Global Digital Pathology Market is segmented by Product, Type, Application, End-use and region. Based on Product, the market is segmented into Scanners, Software, Deployment Model and Storage System. Based on Type, the market is segmented into Human Pathology and Veterinary Pathology. Based on Application, the market is segmented into Drug Discovery & Development, Academic Research and Disease Diagnosis. Based on End-use, the market is segmented into Hospitals, Biotech & Pharma Companies, Diagnostic Labs and Academic & Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Digital Pathology Market

The Global Digital Pathology market is significantly driven by technological advancements including whole-slide imaging (WSI), advanced image analysis tools, and the integration of artificial intelligence (AI). These innovations have revolutionized the field of digital pathology, making it more appealing to healthcare providers by enhancing diagnostic accuracy, boosting operational efficiency, and facilitating automated workflow processes. As a consequence of these developments, digital pathology is becoming an essential component in modern healthcare practices, leading to widespread adoption and contributing to the overall growth of the market. The continuous evolution of these technologies promises to further enhance the capabilities of digital pathology in the future.

Restraints in the Global Digital Pathology Market

The Global Digital Pathology market faces significant constraints due to the complex and labor-intensive nature of integrating existing healthcare IT infrastructures with digital pathology solutions. This challenge is particularly pronounced in institutions that rely on outdated technologies, where compatibility issues and the extensive modifications required can create obstacles to system adoption. These complications can hinder the smooth implementation and optimization of digital pathology workflows, ultimately impeding the overall acceptance of these advanced systems within healthcare organizations and limiting their effectiveness in improving diagnostic processes and patient outcomes.

Market Trends of the Global Digital Pathology Market

The global digital pathology market is witnessing a significant shift towards fully cloud-based solutions, driven by advancements in imaging technology and a growing emphasis on scalable, collaborative, and personalized healthcare. As the demand for eco-friendly diagnostic tools escalates, digital pathology is increasingly being recognized for its ability to facilitate efficient data collection, management, and analysis. The adoption of Whole Slide Imaging (WSI) is a standout trend, enabling pathologists to digitally access and analyze entire tissue slides, significantly improving diagnostic accuracy and workflow efficiency. This market evolution is indicative of a broader move towards innovative healthcare solutions that enhance collaboration and improve patient outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Digital Pathology Market Size by Product & CAGR (2025-2032)

• Market Overview
• Scanners
  • Brightfield Scanners
  • Fluorescence Scanners
  • Other Scanners
• Software
  • Integarted Software
  • Standone Software
• Deployment Model
  • Cloud-Based Model
  • On-Premise Model
  • Hybrid Model
• Storage System

Global Digital Pathology Market Size by Type & CAGR (2025-2032)

• Market Overview
• Human Pathology
• Veterinary Pathology

Global Digital Pathology Market Size by Application & CAGR (2025-2032)

• Market Overview
• Drug Discovery & Development
• Academic Research
• Disease Diagnosis
  • Cancer Cell Detection
  • Others

Global Digital Pathology Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Biotech & Pharma Companies
• Diagnostic Labs
• Academic & Research Institutes

Global Digital Pathology Market Size & CAGR (2025-2032)

• North America (Product, Type, Application, End-use)
  • US
  • Canada
• Europe (Product, Type, Application, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Type, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Type, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Type, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hamamatsu Photonics K.K. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3DHISTECH Ltd. (Hungary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sectra AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Visiopharm A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apollo Enterprise Imaging Corporation (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corista LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Paige.AI, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ibex Medical Analytics Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indica Labs, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Proscia Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Deep Lens Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aiforia Technologies Oyj (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OptraSCAN, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mikroscan Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xilis, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations